Spanish researchers identify 16 proteins related to the response to osteoarthritis treatment
- These proteins are potential biomarkers that could be used to predict the best treatment for each patient
- They analyzed the differences in protein modulation between patients responding to celecoxib or to the combination of chondroitin sulfate and hydrochlorure of glucosamine, and patients not responding to these treatments.
- The results of this study have been presented at the Osteoarthritis World Congress (OARSI) and have been accepted as scientific communication accepted for presentation at the European Congress of Rheumatology (EULAR).
“Osteoarthritis still remains an under diagnosed and under treated disease at all levels of healthcare”
This chronic inflammatory disease affects seven million Spaniards and causes 35 per cent of all visits to primary care centers
Family physicians play a key role in the early detection and treatment of the disease-family physicians are the healthcare professionals who can follow closely the evolution of their patients’ disease
A panel of osteoarthritis experts attending the 34th SEMERGEN national congress held in Malaga praised the efficacy and security of chondroprotection drugs and recommended them as the treatment of choice for osteoarthritis.